Coronary disease & ACS

Higher eicosapentaenoic acid levels and eicosapentaenoic acid/docosahexaenoic acid ratios are associated with lower cardiovascular mortality post-myocardial infarction

Eur J Prev CardiolPublished Prospective cohort study

Authors' conclusion

Our study demonstrates that higher plasma levels of EPA and EPA/DHA ratio are associated with lower CV mortality one year after AMI.

Study context

Population
Patients hospitalised for acute MI
Participants
572 patients
Exposure
Cardiovascular (CV) deaths vs survivors
Outcome
CV mortality
Follow-up
1 year

Main finding

As reported in the abstract

Plasma FA levels by CV mortality · one-year follow-up
GroupEicosapentaenoic acid (EPA)EPA/DHA ratio
Died0.47% (0.28-0.73)0.33 (0.22-0.43)

Died

Eicosapentaenoic acid (EPA)0.47% (0.28-0.73)
EPA/DHA ratio0.33 (0.22-0.43)
Lower EPA in those who died: 0.47% (0.28-0.73) vs. 0.73% (0.52-1.02)
P < 0.001
Lower EPA/DHA ratio in those who died: 0.33 (0.22-0.43) vs. 0.44 (0.33-0.61)
P < 0.001

Observational data: associations, not effects.

Further findings

Inflammatory biomarkers (hs-CRP, interleukin-1β)

More elevated in patients who died

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Higher eicosapentaenoic acid levels and eicosapentaenoic acid/docosahexaenoic acid ratios are associated with lower cardiovascular mortality post-myocardial infarction. Eur J Prev Cardiol. Published 14 October 2025. doi:10.1093/eurjpc/zwaf673

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.